Bevacizumab Demonstrates Prolonged Disease Stabilization in Patients with Heavily Pretreated Metastatic Renal Cell Carcinoma: A Case Series and Review of the Literature

There are now a variety of therapies approved for the treatment of metastatic renal cell carcinoma (RCC). These include the immunotherapeutics, alfa-interferon, and interleukin-2, and agents that target the vascular endothelial growth factor receptor (VEGFR) via its tyrosine kinase, such as sorafeni...

Descripción completa

Detalles Bibliográficos
Autores principales: Agostino, Nicole M., Gingrich, Rebecca, Drabick, Joseph J.
Formato: Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2010
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2913531/
https://www.ncbi.nlm.nih.gov/pubmed/20721275
http://dx.doi.org/10.1155/2010/687043

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2913531/
https://www.ncbi.nlm.nih.gov/pubmed/20721275
http://dx.doi.org/10.1155/2010/687043

Ejemplares similares